Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355193
Status:
COMPLETED
Last Update Posted:
2024-04-09
First Post:
2024-04-08
Brief Title:
The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19 A Trial Clinical Study
Sponsor:
Central South University
Organization:
Central South University
Study Overview
Official Title:
The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19 A Trial Clinical Study
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study has significant implications for research as it provides a basis for further studies on the antiviral effects of LGLQ Oral Liquid encouraging more extensive clinical studies in larger populations and diverse age groups to validate these findings For medical practice the findings suggest that LGLQ can be considered an alternative treatment option for mild cases of COVID-19 especially in managing symptoms like fatigue potentially broadening the range of effective treatments available to healthcare practitioners In terms of policy the demonstrated efficacy of LGLQ could lead to its inclusion in treatment guidelines for COVID-19 and other viral infections fostering a more integrated approach combining Western medicine and Traditional Chinese Medicine in the global fight against pandemics The insights from this study might prompt health policymakers to reassess the potential of herbal formulations in managing and treating infectious diseases and consider them in the development of future healthcare strategies and policies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None